Li X, Zhao Z, Cheng Y, Yan J, Ren F, Jia Y
Cancer Cell Int. 2025; 25(1):90.
PMID: 40082876
PMC: 11907857.
DOI: 10.1186/s12935-025-03725-x.
Xue L, Gao L, Zhou S, Yan C, Zhang X, Lin W
Funct Integr Genomics. 2025; 25(1):63.
PMID: 40082276
DOI: 10.1007/s10142-025-01564-7.
Zhang W, Huang X
Biomark Res. 2025; 13(1):43.
PMID: 40075527
PMC: 11905658.
DOI: 10.1186/s40364-025-00750-w.
Guc E, Treveil A, Leach E, Broomfield A, Camera A, Clubley J
Nat Commun. 2025; 16(1):2374.
PMID: 40064880
PMC: 11893752.
DOI: 10.1038/s41467-025-57470-w.
Tan B, Xu K, Lyu Y, Liang Y, Liang R, Lei K
Commun Biol. 2025; 8(1):394.
PMID: 40057671
PMC: 11890618.
DOI: 10.1038/s42003-025-07819-0.
The epigenetic hallmarks of immune cells in cancer.
Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W
Mol Cancer. 2025; 24(1):66.
PMID: 40038722
PMC: 11881328.
DOI: 10.1186/s12943-025-02255-4.
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.
Griffiths J, Cosgrove P, Medina E, Nath A, Chen J, Adler F
Nat Commun. 2025; 16(1):2132.
PMID: 40032842
PMC: 11876604.
DOI: 10.1038/s41467-025-56279-x.
High-dimensional deconstruction of HNSC reveals clinically distinct cellular states and ecosystems that are associated with prognosis and therapy response.
Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y
J Transl Med. 2025; 23(1):254.
PMID: 40025504
PMC: 11872339.
DOI: 10.1186/s12967-025-06299-4.
Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma.
Zhang M, Zhou G, Xu Y, Wei B, Liu Q, Zhang G
Sci Rep. 2025; 15(1):7213.
PMID: 40021802
PMC: 11871002.
DOI: 10.1038/s41598-025-91401-5.
Scupa: single-cell unified polarization assessment of immune cells using the single-cell foundation model.
Liu W, Zhao Z
Bioinformatics. 2025; 41(3).
PMID: 39999031
PMC: 11893155.
DOI: 10.1093/bioinformatics/btaf090.
The comprehensive potential of AQP1 as a tumor biomarker: evidence from kidney neoplasm cohorts, cell experiments and pan-cancer analysis.
Liu Y, Lyu D, Yao Y, Cui J, Liu J, Bai Z
Hum Genomics. 2025; 19(1):15.
PMID: 39988693
PMC: 11849320.
DOI: 10.1186/s40246-025-00726-9.
Tumor-associated stroma shapes the spatial tumor immune microenvironment of primary Ewing sarcomas.
Kuo C, Giannikou K, Wang N, Warren M, Goodspeed A, Shillingford N
bioRxiv. 2025; .
PMID: 39975230
PMC: 11838416.
DOI: 10.1101/2025.01.31.635996.
Single-cell transcriptomics reveals the multidimensional dynamic heterogeneity from primary to metastatic gastric cancer.
Zhang Y, Yang K, Bai J, Chen J, Ou Q, Zhou W
iScience. 2025; 28(2):111843.
PMID: 39967875
PMC: 11834116.
DOI: 10.1016/j.isci.2025.111843.
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis.
Liu F, Zhang T, Yang Y, Wang K, Wei J, Shi J
BMC Cancer. 2025; 25(1):280.
PMID: 39962461
PMC: 11834279.
DOI: 10.1186/s12885-025-13714-y.
Single-cell and spatial transcriptomics reveal a potential role of ATF3 in brain metastasis of lung adenocarcinoma.
Xu C, Bao J, Pan D, Wei K, Gao Q, Lin W
Transl Lung Cancer Res. 2025; 14(1):209-223.
PMID: 39958219
PMC: 11826269.
DOI: 10.21037/tlcr-24-784.
The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy.
Jumaniyazova E, Lokhonina A, Dzhalilova D, Miroshnichenko E, Kosyreva A, Fatkhudinov T
Cancers (Basel). 2025; 17(3).
PMID: 39941714
PMC: 11815841.
DOI: 10.3390/cancers17030342.
Lactate and lactylation in cancer.
Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y
Signal Transduct Target Ther. 2025; 10(1):38.
PMID: 39934144
PMC: 11814237.
DOI: 10.1038/s41392-024-02082-x.
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer.
Wang C, Li J, Chen J, Wang Z, Zhu G, Song L
Nat Commun. 2025; 16(1):1477.
PMID: 39929832
PMC: 11811181.
DOI: 10.1038/s41467-024-55068-2.
Single cell transcriptome profiling reveals pathogenesis of bullous pemphigoid.
Liang G, Zhao C, Wei Q, Feng S, Wang Y
Commun Biol. 2025; 8(1):203.
PMID: 39922909
PMC: 11807148.
DOI: 10.1038/s42003-025-07629-4.
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Reiss K, Angelos M, Dees E, Yuan Y, Ueno N, Pohlmann P
Nat Med. 2025; .
PMID: 39920391
DOI: 10.1038/s41591-025-03495-z.